Back to Top

"One of today's leaders in investor relations and shareholder services"

Category Archives: Articles

Medical Marijuana, Inc. (MJNA)

MJNA in Washington on Capitol Hill Side by Side with Americans for Safe Access

Medical Marijuana, Inc.  (MJNA)

Obviously, when you purchase marijuana on the street, you’re not always sure what you’re getting. With different potencies and strains and even the fact that people lace weed with other drugs on occasion, buying marijuana from a dealer is a gamble. Not to mention, purchasing it on the streets is illegal. However, now that medical marijuana is becoming more well known and accepted throughout the country, many are lobbying for safe access to medicinal marijuana to alleviate any issues associated with purchasing marijuana and the regulation of it.

Medical Marijuana, Inc. (OTC: MJNA) are among those who are fighting for the cause. They were the ones to pave the way in the United States as the first publicly traded cannabis company. From April 7th to the 11th, representatives from MJNA attended the 5th Annual National Medical Cannabis Unity Conference at Omni Shoreham Hotel in Washington, DC. Experts, including scientists, …

Continue Reading

Posted in Articles| Tagged , , , |
AXIM Biotechnologies, Inc.

AXIM Biotechnologies, Inc. and API Develop Marinol Alternative

AXIM Biotechnologies, Inc.

Medical marijuana has presented life-changing treatment options for patients around the world, but with strict laws in many regions preventing the use of such pharmaceutical alternatives, progress has been gradual. There is still significant stigma surrounding the effects of medical marijuana and its use in a clinical treatment setting. Despite the many positive studies associated with these products, opposition persists in many sectors of the market. Companies such as AXIM Biotechnologies, Inc. (OTCQX: AXIM) have long been at the forefront of medical marijuana research and development, facing opposition from lobbyists and other detractors who seek to keep the status quo within the pharmaceutical industry. Until recently, Insys Therapeutics was one of those companies.

In the past, Insys Therapeutics has been active in the opposition of general marijuana legalization, donating $500,000 to a group called Arizonans for Responsible Drug Policy in the summer of 2016. The group launched a campaign …

Continue Reading

Posted in Articles| Tagged , , , |
Medical Marijuana, Inc. (MJNA)

Medical Marijuana, Inc. Positioned Perfectly as New Studies Showcase How CBD Oil is Effective for Treating Epileptic Children

Medical Marijuana, Inc. (MJNA)

According to the Epilepsy Foundation, the incidence of epilepsy is highest in young children and older adults. There are currently 2.2 million people who are believed to have epilepsy in the United States alone, and many of those suffering are children whose symptoms prevent them from going to school and leading normal childhoods. Epileptic seizures can range from mild and infrequent to being characterized by violent and near-constant convulsions. The problem with many existing treatments for epilepsy is that they quite often come with debilitating side effects, are ineffective, or a combination of both. Children are even more severely affected by many of these negative side effects than adult patients, and their young age may limit the treatment options available to them.

Medical marijuana is an increasingly popular treatment option for children and adults with epilepsy. Around the world, there have been promising case studies on the positive effects …

Continue Reading

Posted in Articles| Tagged , , , |
Rocky Mountain High Brands, Inc. (OTCQB: RMHB)

2017 is Shaping Up to Be a Monumental Year for Rocky Mountain High Brands, Inc.

Rocky Mountain High Brands, Inc. (OTCQB: RMHB)

Big news is in the works for Rocky Mountain High Brands, Inc. (OTCQB: RMHB) The company that specializes in hemp infused food and beverage products and naturally high alkaline water, announced this month that they would be entering into an agreement with L and H Resort System to take over a former Catskill Mountain resort facility.

Listen to Podcast

About Rocky Mountain High Brands

The brand known for creating hemp infused foods and beverages, is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots. The Company recently launched a naturally high alkaline spring water, Eagle Spirit Spring …

Continue Reading

Posted in Articles| Tagged , , |

Bioequivalent Product to Marinol in the Works with AXIM Biotech at the Helm

AXIM Biotechnologies

In recent months, the medical benefits of cannabis have been all over the news. With reports that cannabis oil can reduce and even stop seizures, help patients with memory loss like dementia and Alzheimer’s, and even help to reduce pain associated with chronic illness, it makes sense that more and more biotech companies would be looking to get in on the market.

Earlier this week biotech newcomer AXIM Biotechnologies, Inc. (OTCQX: AXIM) announced that they would be teaming up with a United States based API (Active Pharmaceutical Ingredient) production company to further their production and creation of a dronabinol based functional chewing gum. AXIM is a forerunner in cannabinoid research and have been working for years to help develop solutions like Marinol, a gel capsule containing cannabinoid to help with things like nausea associated with AIDS treatment and chemotherapy.

About AXIM

AXIM has long been part of the cannabinoid …

Continue Reading

Posted in Articles| Tagged , , |

Renowned Doctor Does Study with RSHO-X on LGS (epilepsy) Patients with Incredible Results

MJNA

Lennox-Gastault Syndrome is a severe epileptic disorder that manifests in various forms of seizures. This condition is one of the most severe epilepsies to occur in children. Unfortunately, most LGS patients do not respond well to existing pharmaceutical treatments used to medicate seizures. In many cases, it is impossible to identify the cause of LGS-related seizures, and the seizures themselves are often extremely difficult to manage. LGS may be accompanied by various behavioral and cognitive development issues, and while the condition manifests in childhood, it often continues into adulthood.

Treatment for Lennox-Gastault Syndrome

One of the most difficult aspects of treating LGS in children is the high frequency of seizures that characterizes the syndrome. LGS is also known for being resistant to antiepileptic drugs (AEDs), which can frequently result in debilitating side effects on their own. In a study that ran from January 2016 to February 2017, Dr. Saul …

Continue Reading

Posted in Articles| Tagged , |